← Back to headlines
Novo Nordisk to Cut U.S. Prices for Ozempic and Wegovy
Novo Nordisk announced plans to reduce the U.S. list prices for its popular diabetes and weight-loss drugs, Ozempic and Wegovy, by up to 50%. This move aims to make the medications more affordable for patients.
24 Feb, 19:19 — 24 Feb, 19:19
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Quezon City General Hospital Recognized Among Newsweek’s Top Hospitals in the Philippines
just now
Doctors in Delhi Save Vision of Iraqi Patient with Rare Tumour Using Indigenous Technology
14m ago
New Research Links Cannabis Use to Harmful Mental Health Effects
19m ago
US Plans to Send Hospital Ship to Greenland Despite Rejection
23m ago